These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 34464605)
1. Multiplex immunoassay to measure antibody response to nine HPV vaccine types. Panicker G; Rajbhandari I; Pathak HN; Brady AM; Unger ER J Immunol Methods; 2021 Nov; 498():113136. PubMed ID: 34464605 [TBL] [Abstract][Full Text] [Related]
2. Development and evaluation of multiplexed immunoassay for detection of antibodies to HPV vaccine types. Panicker G; Rajbhandari I; Gurbaxani BM; Querec TD; Unger ER J Immunol Methods; 2015 Feb; 417():107-114. PubMed ID: 25554636 [TBL] [Abstract][Full Text] [Related]
3. Comparison of a VLP-based and GST-L1-based multiplex immunoassay to detect vaccine-induced HPV-specific antibodies in first-void urine. Pattyn J; Panicker G; Willhauck-Fleckenstein M; Van Keer S; Téblick L; Pieters Z; Tjalma WAA; Matheeussen V; Van Damme P; Waterboer T; Unger ER; Vorsters A J Med Virol; 2020 Dec; 92(12):3774-3783. PubMed ID: 32266996 [TBL] [Abstract][Full Text] [Related]
4. Immunogenicity assessment of HPV16/18 vaccine using the glutathione S-transferase L1 multiplex serology assay. Robbins HA; Waterboer T; Porras C; Kemp TJ; Pawlita M; Rodriguez AC; Wacholder S; Gonzalez P; Schiller JT; Lowy DR; Esser M; Matys K; Poncelet S; Herrero R; Hildesheim A; Pinto LA; Safaeian M Hum Vaccin Immunother; 2014; 10(10):2965-74. PubMed ID: 25483632 [TBL] [Abstract][Full Text] [Related]
5. Measurement of Human Papillomavirus-Specific Antibodies Using a Pseudovirion-Based ELISA Method. Toh ZQ; He L; Chen C; Huang A; Russell FM; Garland SM; Reyburn R; Ratu T; Tuivaga E; Frazer IH; Mulholland EK; Licciardi PV Front Immunol; 2020; 11():585768. PubMed ID: 33193410 [TBL] [Abstract][Full Text] [Related]
6. The humoral response to Gardasil over four years as defined by total IgG and competitive Luminex immunoassay. Brown DR; Garland SM; Ferris DG; Joura E; Steben M; James M; Radley D; Vuocolo S; Garner EI; Haupt RM; Bryan JT Hum Vaccin; 2011 Feb; 7(2):230-8. PubMed ID: 21307649 [TBL] [Abstract][Full Text] [Related]
7. Concordance assessment between a multiplexed competitive Luminex immunoassay, a multiplexed IgG Luminex immunoassay, and a pseudovirion-based neutralization assay for detection of human papillomaviruse types 16 and 18. Brown D; Müller M; Sehr P; Pawlita M; Seitz H; Rubio I; Antonello J; Radley D; Roberts C; Saah A Vaccine; 2014 Oct; 32(44):5880-7. PubMed ID: 25148777 [TBL] [Abstract][Full Text] [Related]
8. Development and validation of a multiplex immunoassay for the simultaneous quantification of type-specific IgG antibodies to E6/E7 oncoproteins of HPV16 and HPV18. Layman H; Rickert KW; Wilson S; Aksyuk AA; Dunty JM; Natrakul D; Swaminathan N; DelNagro CJ PLoS One; 2020; 15(3):e0229672. PubMed ID: 32214362 [TBL] [Abstract][Full Text] [Related]
9. Measurement of neutralizing serum antibodies of patients vaccinated with human papillomavirus L1 or L2-based immunogens using furin-cleaved HPV Pseudovirions. Wang JW; Jagu S; Wang C; Kitchener HC; Daayana S; Stern PL; Pang S; Day PM; Huh WK; Roden RB PLoS One; 2014; 9(7):e101576. PubMed ID: 24999962 [TBL] [Abstract][Full Text] [Related]
10. Correlation between ELISA and pseudovirion-based neutralisation assay for detecting antibodies against human papillomavirus acquired by natural infection or by vaccination. Zhao H; Lin ZJ; Huang SJ; Li J; Liu XH; Guo M; Zhang J; Xia NS; Pan HR; Wu T; Li CG Hum Vaccin Immunother; 2014; 10(3):740-6. PubMed ID: 24384608 [TBL] [Abstract][Full Text] [Related]
11. High-throughput pseudovirion-based neutralization assay for analysis of natural and vaccine-induced antibodies against human papillomaviruses. Sehr P; Rubio I; Seitz H; Putzker K; Ribeiro-Müller L; Pawlita M; Müller M PLoS One; 2013; 8(10):e75677. PubMed ID: 24124504 [TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus (HPV) L1 and L1-L2 virus-like particle-based multiplex assays for measurement of HPV virion antibodies. Hernandez BY; Ton T; Shvetsov YB; Goodman MT; Zhu X Clin Vaccine Immunol; 2012 Sep; 19(9):1348-52. PubMed ID: 22761294 [TBL] [Abstract][Full Text] [Related]
13. Development and evaluation of a new non-competitive Luminex immunoassay detecting antibodies against human papillomavirus types 6, 11, 16 and 18. Trevisan A; Wissing MD; Dagenais C; Forest P; Ramanakumar AV; Burchell AN; Franco EL; Coutlée F; Couillard M J Gen Virol; 2021 May; 102(5):. PubMed ID: 34043499 [TBL] [Abstract][Full Text] [Related]
14. Development of a human papillomavirus (HPV) multiplex immunoassay to profile HPV antibodies. Quang C; Chung AW; Kemp TJ; Ratu T; Tuivaga E; Russell FM; Licciardi PV; Toh ZQ J Med Virol; 2024 Jun; 96(6):e29732. PubMed ID: 38874202 [TBL] [Abstract][Full Text] [Related]
15. Evolution of type-specific immunoassays to evaluate the functional immune response to Gardasil: a vaccine for human papillomavirus types 16, 18, 6 and 11. Smith JF; Kowalski R; Esser MT; Brown MJ; Bryan JT Hum Vaccin; 2008; 4(2):134-42. PubMed ID: 18388490 [TBL] [Abstract][Full Text] [Related]
16. Development of a human papillomavirus competitive luminex immunoassay for 9 HPV types. Roberts C; Green T; Hess E; Matys K; Brown MJ; Haupt RM; Luxembourg A; Vuocolo S; Saah A; Antonello J Hum Vaccin Immunother; 2014; 10(8):2168-74. PubMed ID: 25424920 [TBL] [Abstract][Full Text] [Related]
17. Immunogenicity correlation in cynomolgus monkeys between Luminex-based total IgG immunoassay and pseudovirion-based neutralization assay for a 14-valent recombinant human papillomavirus vaccine. Bei L; Zhang X; Meng D; Gao S; Jia J; Zhao D; Luo C; Li X; Qiu H; Xie L J Med Virol; 2022 Aug; 94(8):3946-3955. PubMed ID: 35388509 [TBL] [Abstract][Full Text] [Related]
18. Correlation between direct ELISA, single epitope-based inhibition ELISA and pseudovirion-based neutralization assay for measuring anti-HPV-16 and anti-HPV-18 antibody response after vaccination with the AS04-adjuvanted HPV-16/18 cervical cancer vaccine. Dessy FJ; Giannini SL; Bougelet CA; Kemp TJ; David MP; Poncelet SM; Pinto LA; Wettendorff MA Hum Vaccin; 2008; 4(6):425-34. PubMed ID: 18948732 [TBL] [Abstract][Full Text] [Related]
19. Assessment of HPV 16 and HPV 18 antibody responses by pseudovirus neutralization, Merck cLIA and Merck total IgG LIA immunoassays in a reduced dosage quadrivalent HPV vaccine trial. Krajden M; Cook D; Yu A; Chow R; Su Q; Mei W; McNeil S; Money D; Dionne M; Palefsky J; Karunakaran K; Kollmann T; Ogilvie G; Petric M; Dobson S Vaccine; 2014 Jan; 32(5):624-30. PubMed ID: 24055350 [TBL] [Abstract][Full Text] [Related]
20. Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and HPV-6/11/16/18 vaccine administered according to 2- and 3-dose schedules in girls aged 9-14 years: Results to month 12 from a randomized trial. Leung TF; Liu AP; Lim FS; Thollot F; Oh HM; Lee BW; Rombo L; Tan NC; Rouzier R; Friel D; De Muynck B; De Simoni S; Suryakiran P; Hezareh M; Folschweiller N; Thomas F; Struyf F Hum Vaccin Immunother; 2015; 11(7):1689-702. PubMed ID: 26062002 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]